On January 1, 2013, AbbVie was founded, a global biopharmaceutical company with the focus and capabilities to address some of the world’s greatest health challenges. AbbVie has the stability, resources, expertise, and passion to discover, develop, and bring to market groundbreaking science to solve the biggest health problems that face the world today and tomorrow.
We are 28,000 people focused on developing new products and new ways to help people manage some of the most serious health conditions. We are scientists, researchers, communicators, manufacturing specialists, and regulatory experts. We also are parents, brothers, sisters, friends, community leaders, volunteers, and more. We have a lot in common with the people we serve, and we come together every day to create, discover, and deliver new ways to improve people’s health.
At AbbVie, we have the expertise of a proven pharmaceutical leader and the focus and passion of an entrepreneur and innovator. The result is something rare in health care today – a global biopharmaceutical company that has the ability to discover and advance innovative therapies and meet the health needs of people and societies around the globe.
Committed to Patient-Centered Innovation
When it comes to innovating, AbbVie starts with the patient. We draw on our deep expertise in some of the most difficult-to-treat diseases and on our understanding of the patient journey to identify opportunities to create better outcomes at every stage. This patient-centered approach to discovery and development ensures we remain focused on our goal of improving lives.
Contact
AbbVie South Africa Pty Ltd
Abbott Place
219 Golf Club Terrace
Constantia Kloof
Telephone: 011 858 2000
Fax to email: 086 605 2238
Customer care line: 0800 11 34 11
Web: abbvie.com
Abbvie GM for South Africa Christo Kruger highlights the various types of projects that the Public Health Enhancement Fund (PHEF) is pursuing to help alleviate the country’s currently overburdened healthcare…
Mrs. Reid, how would you define and describe the generic part of the South African pharmaceutical market? Linda Reid: South Africa is very much a branded generics market, and not…
In 2010, South Africa officially joined the BRICS grouping. The Indian and Russian work environments are familiar to you, considering your significant experience in these countries. How would you compare…
Ms Beaumont, can you describe the association to our readers and its main objectives? Innovative Medicines South Africa (IMSA) represents manufacturers of research-based medicines, ie they market the products of…
See our Cookie Privacy Policy Here
